Literature DB >> 20844158

The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review.

Michael A Mont1, Michael G Zywiel, David R Marker, Mike S McGrath, Ronald E Delanois.   

Abstract

BACKGROUND: An asymptomatic hip with osteonecrosis is typically discovered as the contralateral hip of a patient with one symptomatic joint. Treatment of the asymptomatic hip is controversial. While some authors claim a benign natural history, others have reported a rate of femoral head collapse exceeding 50%. The purpose of this report was to systematically review the published literature regarding asymptomatic osteonecrosis of the femoral head to evaluate the overall prevalence of progression to symptomatic disease and/or femoral head collapse as well as to determine whether various radiographic and demographic factors influence progression of the disorder.
METHODS: A comprehensive literature search was performed to identify prognostic studies evaluating asymptomatic hip osteonecrosis. Demographic, radiographic, and outcome data were extracted from all relevant studies. The prevalence of progression to symptomatic disease and/or femoral head collapse was determined. Next, outcomes were stratified by lesion size, lesion location, radiographic stage, associated risk factors and/or disease, and the level of evidence of the study.
RESULTS: Sixteen studies that included a total of 664 hips were available for an analysis of outcomes. Overall, 394 hips (59%) had progression to symptoms or collapse. Differences in outcomes based on lesion size, lesion location, and radiographic stage at the time of diagnosis were seen. Small, medially located lesions had the best prognosis, with a prevalence of collapse of <10%. Patients with sickle cell disease had the highest frequency of progression, and those with a history of systemic lupus erythematosus had the most benign course.
CONCLUSIONS: Data extracted from previously published studies suggest that asymptomatic osteonecrosis has a high prevalence of progression to symptomatic disease and femoral head collapse. While small, medially located lesions have a low rate of progression, the natural history of asymptomatic medium-sized, and especially large, osteonecrotic lesions is progression in a substantial number of patients. For this reason, it may be beneficial to consider joint-preserving surgical treatment in asymptomatic patients with a medium-sized or large, and/or laterally located, lesion.

Entities:  

Mesh:

Year:  2010        PMID: 20844158     DOI: 10.2106/JBJS.I.00575

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  131 in total

Review 1.  Glucocorticoid-induced osteonecrosis.

Authors:  Robert S Weinstein
Journal:  Endocrine       Date:  2011-12-15       Impact factor: 3.633

Review 2.  Osteonecrosis in children after therapy for malignancy.

Authors:  Sue C Kaste; Evguenia J Karimova; Michael D Neel
Journal:  AJR Am J Roentgenol       Date:  2011-05       Impact factor: 3.959

3.  Problems with the pathological diagnosis of osteonecrosis.

Authors:  Shobha Parajuli; John R Fowler; Easwaran Balasubramanian; William R Reinus; John P Gaughan; Daniel I Rosenthal; Jasvir S Khurana
Journal:  Skeletal Radiol       Date:  2016-01       Impact factor: 2.199

4.  Lower-limb MRI in the staging and re-staging of osteonecrosis in paediatric patients affected by acute lymphoblastic leukaemia after therapy.

Authors:  D Ippolito; A Masetto; C Talei Franzesi; P A Bonaffini; A Sala; A Biondi; S Sironi
Journal:  Skeletal Radiol       Date:  2016-01-19       Impact factor: 2.199

5.  CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.

Authors:  Cody C Wyles; Christopher R Paradise; Matthew T Houdek; Susan L Slager; Andre Terzic; Atta Behfar; Andre J van Wijnen; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2019-08       Impact factor: 4.176

6.  Investigating clinical failure of core decompression with autologous bone marrow mononuclear cells grafting for the treatment of non-traumatic osteonecrosis of the femoral head.

Authors:  Lihua Liu; Fuqiang Gao; Wei Sun; Yunting Wang; Qingyu Zhang; Bailiang Wang; Liming Cheng; Zi-Rong Li
Journal:  Int Orthop       Date:  2018-04-13       Impact factor: 3.075

7.  Tardive hip disease diagnosis in a young adult with sickle cell disease.

Authors:  A A Bokolombe; F Samato; T Lukinu; M B Ekila; M N Aloni
Journal:  Afr Health Sci       Date:  2013-03       Impact factor: 0.927

8.  Arthroscopic treatment of labral tears and concurrent avascular necrosis of the femoral head in young adults.

Authors:  David M Beck; Brian K Park; Thomas Youm; Theodore S Wolfson
Journal:  Arthrosc Tech       Date:  2013-09-23

9.  Osteonecrosis of the femoral head: diagnosis and classification systems.

Authors:  Ho-Rim Choi; Marvin E Steinberg; Edward Y Cheng
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

10.  Pain relief following osteonecrosis of the femoral head treated by free vascularized fibular grafting.

Authors:  Sheng-Bao Chen; You-Shui Gao; Zhen-Hong Zhu; Dong-Xu Jin; Xiang-Guo Cheng; Chang-Qing Zhang
Journal:  Eur J Orthop Surg Traumatol       Date:  2011-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.